Toner also said that Sam Altman gave the board inaccurate details about the protection procedures the corporate experienced set up and that he didn’t disclose his involvement during the OpenAI Startup Fund. A March 2023 paper examined ChatGPT's software in clinical toxicology. The authors observed the AI "fared well" in https://chatgptlogin10875.full-design.com/5-simple-techniques-for-chatting-gpt-72223003